Cumberland Pharmaceuticals Inc (CPIX): Shareholders' Equity
$24.88M
As of 2025-12-31
$17.44M
As of 2026-06-30
-11.8%
3-year compound annual growth
-11.9%
5-year compound annual growth
-10.7%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.88M | +8.9% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $22.85M | -22.8% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $29.60M | -18.4% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $36.27M | -15.3% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $42.81M | -8.9% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $46.99M | -8.1% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $51.12M | -8.5% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $55.84M | -12.9% | 2020-03-20, Balance as of period end |
| 2017-12-31 | $64.12M | -12.5% | 2019-03-12, Balance as of period end |
| 2016-12-31 | $73.25M | -4.7% | 2018-03-09, Balance as of period end |
| 2015-12-31 | $76.89M | -4.8% | 2017-03-13, Balance as of period end |
| 2014-12-31 | $80.76M | +1.6% | 2016-03-14, Balance as of period end |
| 2013-12-31 | $79.47M | -7.3% | 2015-03-09, Balance as of period end |
| 2012-12-31 | $85.70M | +3.3% | 2014-03-11, Balance as of period end |
| 2011-12-31 | $82.93M | +6.6% | 2013-03-12, Balance as of period end |
| 2010-12-31 | $77.78M | n/a | 2012-03-07, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $24.88M | +8.9% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$33.66M | n/m |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $17.67M | -13.0% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $35.27M | +100.4% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $381.93M | -9.1% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $614.71M | -9.0% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $518.36M | +147.4% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $10.48M | +136.4% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$122.76M | n/m |
Compare CPIX, AQST, INBP, XLO side by side · Screen every company in Pharmaceutical Preparations ↗